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Abstract: Since the 1960s, more than 20,000 compounds were discovered from marine 
organisms. In this paper we performed a quantitative analysis for the novel marine natural 
products reported between 1985 and 2008. The data was extracted mainly from the reviews 
of Faulkner and Blunt [1–26]. The organisms producing these marine natural products are 
divided  into  three  major  biological  classes:  marine  microorganisms  (including 
phytoplankton), marine  algae and marine invertebrate. The marine natural products are 
divided into seven classes based on their chemical structure: terpenoids, steroids (including 
steroidal  saponins),  alkaloids,  ethers  (including  ketals),  phenols  (including  quinones), 
strigolactones,  and  peptides.  The  distribution  and  the  temporal  trend  of  these  classes 
(biological classes and chemical structure classes) were investigated. We hope this article 
provides a comprehensive perspective on the research of marine natural products. 
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1. Introduction 
Marine natural products chemistry was conceived in 1951 when Bergmann and Feeny reported on 
the  isolation  of  the  unusual  nucleosides  spongouridin  and  spongothymidin  from  the  sponge 
Cryptotethya crypta, which served as lead structures for antiviral drugs such as Ara-A [27]. More than 
a decade later, Weinheimer and Spragginsthe discovered prostaglandins in the Caribbean gorgonian 
Plexaura homomalla at  the same time as prostaglandins had just been discovered to be important 
mediators in the human body, which served as further stimulus in the search for new drugs from the 
sea [28]. In 1967, a small symposium was held in Rhode Island, USA, with the ambitious title ―Drugs 
from the Sea‖ [29]. It is the first academic meeting about finding drugs from marine natural products. 
Although the tone and theme of the meeting was somewhat hesitant, it symbolized marine natural 
products chemistry’s birth! In general a few novel potential structures for drugs were discovered from 
marine source between 1950 and 1980. D.J. Faulkner said, ―Marine Natural Products Chemistry is 
essentially a child of the 1970s‖ [30]. 
During 1980s the child—Marine Natural Products Chemistry entered adolescence. Novel marine 
natural products developed rapidly. More and more marine natural products were investigated on a 
broad spectrum of pharmacological activity.  
From 1984, D.J. Faulkner reported a series of annual reviews about marine natural products [1–18]. 
After 2003, J.W. Blunt and his coworkers took over this work [19–26]. The list of compounds in these 
reviews is by no means exhaustive, but they do cover the most novel marine natural compounds every 
year. In this paper, the data mainly from these reviews was quantitatively analyzed. We hope this 
article may provide a comprehensive perspective in the research of marine natural products. 
2. Data and Methods 
Data used in this paper were obtained from a marine natural products database, which was set up by 
our research group [31]. The data of this database quote mainly from the reviews of Faulkner and 
Blunt  (we  add  the  data  reported  before  1980  and  published  in  Chinese).  We  only  selected  the 
compounds which were isolated from marine organisms. From the original paper of every marine 
natural product, the biological chemical and pharmacological information was abstracted and inputted 
into the database. Now the database includes a data collection of 12,322 novel compounds isolated 
from marine organisms. In this paper we performed a quantitative analysis for these marine natural 
products. Based on their chemical structure, these natural products are divided into seven classes: 
terpenoids,  steroids  (including  steroidal  saponins),  alkaloids,  ethers  (including  ketals),  phenols 
(including quinones), strigolactones, and peptides. We also study the organism producing these marine 
natural products. We used the Faulkner and Blunt’s biological classification to assign organisms to 
three major biological classes, marine microorganisms (including phytoplankton), marine algae and 
marine invertebrate. Marine microorganisms (including phytoplankton) included marine actinomycete, 
marine fungi, marine bacteria and phytoplankton (actinomycete was independently researched due to 
its unique metabolites). Marine algae include green algae, golden algae, red algae, brown algae and 
diatoms. Marine invertebrate include protozoa, porifera, cnidarians, bryozoa, molluscs, echinoderms  
and chordates. Mar. Drugs 2011, 9  
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3. Results and Analyses 
3.1. Temporal Distribution 
The trends which exhibited a number of novel products obtained from marine organisms are shown 
in Figure 1; these results are based on the information obtained from the database. Before 1985, natural 
products discovered annually were less than 100; this number, however, increased to over 300 in 1987, 
and remained at a constant level of about 500 products per year in the late 1990s. Generally speaking, 
the marine natural products chemistry has developed rapidly since the mid-1980s. Our data cannot 
cover the history of marine natural products completely (Faulkner’s reviews began in 1984). However, 
from  other  reviews  [3–4,32–34]  we  reached  a  similar  conclusion.  The  increase  in  exploitation  of 
marine organisms to obtain novel products has been coincident with the invention and development of 
the  high-resolution  nuclear  magnetic  resonance  spectrometer  (NMR).  In  the  1970s,  the  NMR 
developed at a high speed, FT-NMR (1970), commercial superconductor magnet (1975) and 2D-NMR 
(1980)  [35]  appeared  in  succession.  In  fact  NMR  instruments  play  a  key  role  in  the  structure 
elucidation of marine natural products structure. 
Figure 1. Temporal trend in the number of novel products obtained from marine organisms. 
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3.2. Species Distribution 
Figure  2  shows  the  trends  in  the  number  of  novel  compounds  isolated  from  different  marine 
organisms  between  1985  and  2008.  The  number  of  compounds  isolated  per  year  from  marine 
invertebrate increased from 1985 to 1991 and increased steadily to above 350 after 1991. The number 
of compounds from marine algae changed in a small range, varying between 50 and 100. The number 
of compounds from marine microorganisms (including phytoplankton) increased slowly from less than 
50 in 1980s to over 100 in 2008. Mar. Drugs 2011, 9  
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Figure  2.  Temporal  trends  in  the  number  of  novel  compounds  isolated  from  different 
marine  organisms  between  1985  and  2008.  ▲,  marine  invertebrate;  ■,  marine  algae;  
, Marine microorganisms (including phytoplankton). 
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3.2.1. Novel Compounds Isolated from Marine Invertebrates 
Until 2008, the majority of novel compounds from marine organisms were isolated from marine 
invertebrates—approximately  75%  of  the  compounds  were  isolated  from  marine  invertebrates 
belonging  to  the  phyla  Porifera(mostly  sponge)  and  Coelenterate(mostly  coral).  This  proportion 
remained between 1985 and 2008 (Figures 3 and 4). Most novel compounds were isolated from sponge 
and coral, as the sponge is most widely distributed in the world and coral grows in the place with  
the  richest  biodiversity,  i.e.,  the  tropic  ocean.  However,  it  is  difficult  to  cultivate  most  marine 
invertebrate on a large-scale. For example, ET-743 is a promising anti-cancer agent yet 1 metric ton 
(wet  weight)  of  the  tunicate  E.  turbinate  has  to  be  harvested  and  extracted  in  order  to  obtain 
approximately 1 g ET-734 [36]. Therefore, economically viable chemical synthesis techniques are 
essential for the large-scale development of these products.  
3.2.2. Novel Compounds Isolated from Marine Algae  
Marine  algae  became  an  industrial  resource  much  earlier  than  marine  invertebrate  and  marine 
microorganisms (including phytoplankton). This is mainly based on farming of edible species or on the 
production  of  agar,  carrageenan  and  alginate.  In  recent  years,  pharmaceutical  firms  have  started 
looking for marine algae in their search for new drugs from marine natural products [37]. According to 
our statistics, most of the novel compounds were isolated from red algae, brown algae and green algae 
(Figures 5 and 6). By pharmacological investigation these novel compounds have shown promising 
biological activities. Most species of red, brown and green algae have been utilized on an industrial 
scale for one hundred years, which indicates that the novel compounds from marine algae are more 
suitable as potential drugs than those from marine invertebrate. Mar. Drugs 2011, 9  
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Figure  3. The number  of novel compounds isolated from marine invertebrate between 
1985 and 2008. 
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Figure  4.  Temporal  trends  in  the  number  of  novel  compounds  isolated  from  marine 
invertebrate between 1985 and 2008. *, Chordates; ■, cnidarians; ▲, molluscs;  , porifera;  
●, echinoderms. 
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Figure 5. The number of novel compounds isolated from marine algae between 1985 and 2008. 
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Figure 6. Temporal trends in the number of novel compounds isolated from marine algae 
between 1985 and 2008. ■, brown algae; ▲, Red algae;  , green algae.  
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3.2.3. Novel Compounds Isolated from Marine Microorganisms (including Phytoplankton) 
Marine microorganism was regarded as one of the potential sources for the discovery of novel 
structures for new drugs [38,39]. According to our statistics, the number of novel compounds isolated 
from marine microorganisms (including phytoplankton) was small initially but has been increasing 
since 1997 (Figures 7 and 8). In the last decade, more and more marine natural product chemists have 
focused on the marine microorganisms (including phytoplankton). Compared with invertebrate and 
algae,  microorganism  multiplies  faster  and  easier  to  large  scale  cultivation.  In  recent  years,  the 
investigation of marine microorganisms (including phytoplankton) natural products has been driven 
forward  by  microbial  genetics.  Piel  et  al.  answered  unsolved  questions  on  the  origin  of  natural 
products  by  cloning  the  pederin  biosynthesis  gene  cluster  from  the  symbiotic  bacterium  of  the 
Paederus beetle [40]. Furthermore, the genome sequencing of the most promising bacterial strains 
paves the way to discover and mine orphan biosynthetic clusters encoding as yet unexpressed novel 
compounds. For example, the presence of approximately 39 different biosynthetic loci were revealed 
in the genome of the marine bacterium Salinispora arenicola (GenBank accession No. CP000850) [41]. 
These  biosynthetic  loci  would  be  a  tremendous  source  of  new  chemistry  to  await  discovery  and 
evaluation. The strong interplay between classical natural product chemistry and modern microbial 
genetics and bioinformatics will therefore help to overcome supply and sustainability issues of the past 
and to promote marine microorganism natural products as a well-recognized alternative for future drug 
discovery programs [42]. Mar. Drugs 2011, 9  
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Figure  7.  The  number  of  novel  compounds  isolated  from  marine  microorganisms 
(including phytoplankton) between 1985 and 2008. 
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Figure  8.  Temporal  trends  in  the  number  of  novel  compounds  isolated  from  marine 
microorganisms (including phytoplankton) between 1985 and 2008. ■, Fungi; ▲, bacteria; 
, actinomycetes; × , Phytoplankton. 
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3.3. Chemical Compounds Isolated from Marine Organisms 
According to our statistics, the chemical structures are divided into seven classes. The amount of 
terpenoids and alkaloids was the largest  (Figure 9). The amount of all structure classes increased 
between 1985 and 2008. The proportion of terpenoids decreased from 50% to 30–40% in the late 
1980s and then stabilized at that level (Figure 10). Obviously over the last twenty years chemical 
technology  has  progressed  rapidly,  including  high  resolution  MS,  high  field  NMR  and  high 
performance LC, so that marine natural products were no longer limited to just a few structure classes. 
Equipped with a Micro-probe, the High-field FT NMR extended the research of marine natural product 
to below 1 mg. Chlipala et al. researched two new marine polyketide metabolites, both less than 1 mg 
(0.3  mg,  0.8  mg)  [43].  The  use  of  900 MHz  cryoprobe  NMR  allowed  the  elucidation  of  the  2D Mar. Drugs 2011, 9  
 
 
521 
structure. The cryoprobe probe, capillary probe and Mano probe, were used in the research of marine 
natural  products  in  smaller  amounts  [44,45].  This  new  technology  expanded  the  scope  of  marine 
natural  products.  Among  the  chemical  structure  classes,  the  number  of  marine  invertebrate  is  the 
largest (Figure 11). This result is in accordance with Figure 2. There have been no novel sterides 
isolated  from  marine  microorganisms  (including  phytoplankton).  Our  collection  is  by  no  means 
exhaustive  so  it  is  credible  that  a  small  amount  of  novel  sterides  were  discovered  from  marine 
microorganisms  (including  phytoplankton).  In  the  decades  our  research  group  focused  on  marine 
microorganisms,  we  did  not  discover  any  novel  sterides.  All  of  the  sterides  are  quite  familiar  to 
chemists, for example ergosterin and peroxide ergosterin. We cannot give a reasonable explanation, 
but we hope this problem can be solved in the future by more investigation. 
Figure  9.  Distribution  of  the  chemical  compounds  isolated  from  marine  organisms 
between 1985 and 2008. 
0
500
1000
1500
2000
2500
3000
Terpenes Sterides Alkaloid Aether
&Ketal
Hydroxybenzene
&Chinone
Lactone Peptide
N
u
m
b
e
r
 
o
f
 
n
a
t
u
r
a
l
 
p
r
o
d
u
c
t
s
 
Figure 10. Temporal trends in the percentage of marine natural products reported from 
1985 to 2008. *, Peptides; ■, steroids; ▲, alkaloids;  , terpenoids. 
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Figure  11. Distribution  of  novel compounds  isolated  from marine organisms, between 
1985 and 2008. 
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4. Conclusions and Prospects 
Unlike terrestrial organisms, marine organisms  have to adapt  to extreme marine  environmental 
conditions such as high pressure, high salt concentration, low nutrient concentration, low but steady 
temperature  (except  the  high  temperature  near  underwater  volcanoes  and  the  extremely  low 
temperature  in  polar  regions),  limited  sunlight,  and  low  oxygen  content.  To  acclimatize  to  these 
conditions,  marine organisms possess unique characteristics that  differentiate them from terrestrial 
organisms  in  many  aspects,  such  as  metabolism,  behavior,  information  transfer,  and  adaptation 
strategy. These characteristics are helpful in determining the differences between terrestrial and marine 
organisms in regards to mechanisms of secondary metabolism and enzyme reactions. These differences 
are responsible for the diversity in the secondary metabolism of marine organisms. 
As discussed in this paper, a broad outlook for marine natural products has been displayed in drug 
development.  The  marine  natural  products  isolated  from  marine  invertebrate  have  a  rich  novel 
chemical structure. As large-scale industrial breeding of most marine invertebrate is difficult, most of 
these structures have been used as a leader structure for chemical or biological synthesis. In contrary to 
terrestrial organism less novel compounds have been discovered from marine algae (plant) than from 
marine invertebrate (animal). This is possibly attributable in part to the simpler anatomical structure 
and reproductive mode of marine algae. Remarkably there are more Multi-halogenated compounds 
isolated  from  marine  algae;  most  displaying  strong  bioactivity.  Benefiting  from  easy  industrial 
culturing and the application of gene technology, marine microorganism (including phytoplankton) is 
the most promising field in which to develop new drugs. In addition, more and more potential novel 
compounds  isolated  from  marine  invertebrates  proved  to  be  biosynthesized  by  mutualistic 
microorganisms [46]. These microbes contain biosynthetic genes for use in potential compounds [47]. 
Tracing  and  cloning  these  genes  would  create  effective  heterologous  producers.  Using  this 
metabolic engineering  approach  opens  a  new  way  to  develop  potential  compounds  isolated  from 
marine invertebrate.  Mar. Drugs 2011, 9  
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The vast ocean, which has an area of about 360 million km
2, possesses incredible resources of novel 
compounds for investigation by natural product chemists, and marine natural products continue to 
contribute to novel drug discovery and play a leading role in this field. We believe that the ocean, 
which  hosts  approximately  87%  of  the  Earth’s  life,  offers  immense  potential  for  the  discovery 
of pharmaceuticals.  
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